Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression

World Journal of Gastroenterology

Volumn 19, Issue 44, 2013, Pages 8071-8077

  Shang, Jing Juan ^a   Yuan, Jian Ye ^b   Xu, Hui ^a   Tang, Rong Zhu ^a   Dong, Yue Bin ^a   Xie, Jian Qun ^b  

^a SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Shugan decoction; Substance P; Sustained visceral hyperalgesia; Transient receptor potential vanilloid 1; Visceral hypersensitivity; Water avoidance stress

Indexed keywords

CHINESE DRUG; PINAVERIUM BROMIDE; SHUGAN; SUBSTANCE P; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ABDOMINAL REFLEX; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; COLON; CONTROLLED STUDY; DRUG MEGADOSE; EXTRACTION; GENE EXPRESSION; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN THRESHOLD; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

SHUGAN-DECOCTION; SUBSTANCE P; SUSTAINED VISCERAL HYPERALGESIA; TRANSIENT RECEPTOR POTENTIAL VANILLOID 1; VISCERAL HYPERSENSITIVITY; WATER AVOIDANCE STRESS;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; COLON; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HYPERALGESIA; MALE; PAIN THRESHOLD; RATS; RATS, WISTAR; REFLEX; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SUBSTANCE P; TRPV CATION CHANNELS; VISCERAL AFFERENTS;

EID: 84888596805     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i44.8071     Document Type: Article

References (31)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491. [PMID: 16678561]
2. Su AM, Shih W, Presson AP, Chang L. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil 2013; Epub ahead of print. [PMID: 23991913 DOI: 10.1111/nmo.12220]
3. Mulak A, Paradowski L. Anorectal function and dyssynergic defecation in different subgroups of patients with irritable bowel syndrome. Int J Colorectal Dis 2010; 25: 1011-1016. [PMID: 20411267 DOI: 10.1007/s00384-010-0950-5]
4. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007; 19: 62-88. [PMID: 17280586]
5. Blackshaw LA, Brookes SJ, Grundy D, Schemann M. Sensory transmission in the gastrointestinal tract. Neurogastroenterol Motil 2007; 19: 1-19. [PMID: 17280582]
6. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288: 306-313. [PMID: 10764638 DOI: 10.1126/science.288.5464.306]
7. Neri M. Irritable bowel syndrome, inflammatory bowel disease and TRPV1: how to disentangle the bundle. Eur J Pain 2013; 17: 1263-1264. [PMID: 24006367 DOI: 10.1002/ j.1532-2149.2013.00345.x]
8. Gazzieri D, Trevisani M, Springer J, Harrison S, Cottrell GS, Andre E, Nicoletti P, Massi D, Zecchi S, Nosi D, Santucci M, Gerard NP, Lucattelli M, Lungarella G, Fischer A, Grady EF, Bunnett NW, Geppetti P. Substance P released by TRPV1expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med 2007; 43: 581-589. [PMID: 17640568 DOI: 10.1016/j.freeradbio med.2007.05.018]
9. Bradesi S, Kokkotou E, Simeonidis S, Patierno S, Ennes HS, Mittal Y, McRoberts JA, Ohning G, McLean P, Marvizon JC, Sternini C, Pothoulakis C, Mayer EA. The role of neurokinin 1 receptors in the maintenance of visceral hyperalgesia induced by repeated stress in rats. Gastroenterology 2006; 130: 1729-1742. [PMID: 16697737 DOI: 10.1053/ j.gastro.2006.01.037]
10. Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007; 56: 1066-1071. [PMID: 17324974]
11. Pan XX, Xie JQ. Clinical observe of Shuganyin in treatment of irritable bowel syndrome. Shanghai Zhongyiyao Daxue Xuebao 2006; 20: 48-50
12. Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 2005; 289: G42-G53. [PMID: 15746211 DOI: 10.1152/ ajpgi.00500.2004]
13. Chaloner A, Greenwood-Van Meerveld B. Sexually dimorphic effects of unpredictable early life adversity on visceral pain behavior in a rodent model. J Pain 2013; 14: 270-280. [PMID: 23348370 DOI: 10.1016/j.jpain.2012.11.008]
14. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-1285. [PMID: 11054385]
15. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001; 280: G519-G524. [PMID: 11254476]
16. Zhu Y, Zheng X, Cong Y, Chu H, Fried M, Dai N, Fox M. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol 2013; 108: 1516-1525. [PMID: 23917444 DOI: 10.1038/ ajg.2013.198]
17. Qu R, Tao J, Wang Y, Zhou Y, Wu G, Xiao Y, Hu CY, Jiang X, Xu GY. Neonatal colonic inflammation sensitizes voltagegated Na(+) channels via upregulation of cystathionine β-synthetase expression in rat primary sensory neurons. Am J Physiol Gastrointest Liver Physiol 2013; 304: G763-G772. [PMID: 23449670 DOI: 10.1152/ajpgi.00466.2012]
18. Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 2013; 25: e272-e282. [PMID: 23433203 DOI: 10.1111/nmo.12103]
19. Jones RC, Xu L, Gebhart GF. The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 2005; 25: 10981-10989. [PMID: 16306411 DOI: 10.1523/JNEURO-SCI.0703-05.2005]
20. Chan CL, Facer P, Davis JB, Smith GD, Egerton J, Bountra C, Williams NS, Anand P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003; 361: 385-391. [PMID: 12573376]
21. Facer P, Knowles CH, Tam PK, Ford AP, Dyer N, Baecker PA, Anand P. Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine. J Pediatr Surg 2001; 36: 1679-1684. [PMID: 11685701 DOI: 10.1053/jpsu.2001.27959]
22. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-929. [PMID: 18252749 DOI:10.1136/gut.2007.138982]
23. Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J, Szolcsányi J, Masclee AA. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain 2013; 17: 1299-1306. [PMID: 23529955 DOI: 10.1002/ j.1532-2149.2013.00309.x]
24. Suckow SK, Anderson EM, Caudle RM. Lesioning of TRPV1 expressing primary afferent neurons prevents PAR-2 induced motility, but not mechanical hypersensitivity in the rat colon. Neurogastroenterol Motil 2012; 24: e125-e135. [PMID: 22168801 DOI: 10.1111/j.1365-2982.2011.01848.x]
25. Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today 2009; 14: 56-67. [PMID: 19063991 DOI:10.1016/j.drudis.2008.11.005]
26. Ravnefjord A, Brusberg M, Kang D, Bauer U, Larsson H, Lindström E, Martinez V. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats. Eur J Pharmacol 2009; 611: 85-91. [PMID: 19344705 DOI:10.1016/j.ejphar.2009.03.058]
27. Liang C, Luo H, Liu Y, Cao J, Xia H. Plasma hormones facilitated the hypermotility of the colon in a chronic stress rat model. PLoS One 2012; 7: e31774. [PMID: 22363728 DOI:10.1371/journal.pone.0031774]
28. Lan C, Tang CW. Effects of substance P on the activity of intestinal mucosal mast cells in rats with multiple organ failure. Zhonghua Xiaohua Zazhi 2003; 23: 271-274
29. Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, Johnson DA, Turner MJ, Whitehead WE. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci 2004; 49: 1236-1243. [PMID: 15387352]
30. Li J, Micevych P, McDonald J, Rapkin A, Chaban V. Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats. J Neurosci Res 2008; 86: 2746-2752. [PMID: 18478547 DOI: 10.1002/jnr.21714]
31. Andrew D, Greenspan JD. Mechanical and heat sensitization of cutaneous nociceptors after peripheral inflammation in the rat. J Neurophysiol 1999; 82: 2649-2656. [PMID: 10561434]